Dr. Sara DuMond
appointed Dr. Sara DuMond to serve on the Board as an “independent” director to fill the vacancy created by that action. The appointment is effective October 21, 2024.
Highest-materiality recent filing
United Bankshares shareholders elect directors, ratify auditor, approve say-on-pay
All 14 director nominees elected; votes in favor ranged from ~98.7M to ~104.7M.
UBSI Q1 net income $124.2M ($0.89), up 47% YoY; repurchased 1.7M shares at $39.92
Q1 2026 diluted EPS $0.89 vs $0.59 YoY and $0.91 in Q4 2025; net income $124.2M.
United Bankshares posts record FY2025 earnings of $464.6M ($3.27 EPS); Q4 EPS $0.91
Record annual net income $464.6M ($3.27 EPS) in FY2025, up 24.5% from FY2024's $373.0M ($2.75 EPS).
United Bankshares approves new buyback plan for up to 5M shares (~3.6% of outstanding)
Board approved 2025 Plan to repurchase up to 5M shares of common stock, replacing the 2022 Plan terminated Nov 20, 2025.
UBSI reports record Q3 EPS of $0.92; NPLs surge to $117M on two large CRE loans
Q3 net income $130.7M ($0.92 diluted), up from Q2 $120.7M ($0.85) and Q3 2024 $95.3M ($0.70).
United Bankshares enters Change in Control Agreements with four top executives
CEO Adams and President Consagra get 3x base salary plus target bonus on qualifying termination after change in control.
United Bankshares posts record Q2 net income of $120.7M, diluted EPS $0.85
Net income of $120.7M ($0.85 EPS) vs $96.5M ($0.71) in Q2 2024, up 25% YoY.
United Bankshares shareholders approve 2025 Equity Incentive Plan, elect directors at annual meeting
2025 Equity Incentive Plan approved with 102.7M for vs 3.7M against; effective immediately.
United Bankshares Q1 EPS $0.59; record NII $260.1M, Piedmont deal closed
Net income $84.3M ($0.59 diluted EPS) vs. $86.8M ($0.64) Q1 2024; revenue up on Piedmont acquisition.
United Bankshares Q4 EPS $0.69, full-year $2.75; closes $2.4B asset acquisition of Piedmont
Q4 2024 net income $94.4M ($0.69 diluted EPS) vs $0.59 in Q4 2023; full-year $373.0M ($2.75) vs $366.3M ($2.71).
United Bankshares completes acquisition of Piedmont Bancorp; combined assets >$32B
Each Piedmont share converted into 0.300 share of UBSI common stock plus cash for fractional shares.
UBSI receives all regulatory approvals for Piedmont Bancorp merger; closing expected early 2025
Federal Reserve Board approval received Nov 29, 2024; state banking approvals already in hand.
United Bankshares Q3 EPS $0.70; net income $95.3M, down slightly YoY; Piedmont merger on track
Diluted EPS $0.70 vs $0.71 YoY and QoQ; net income $95.3M, down from $96.2M in Q3 2023.
United Bankshares appoints Dr. Sara DuMond, pediatrician and CEO, to board effective Oct 21, 2024
Dr. Sara DuMond appointed as independent director effective Oct 21, 2024; board size increased to 15.
United Bankshares Q2 EPS $0.71 beats Q1 and YoY; NIM expands; Piedmont merger on track
Q2 net income $96.5M ($0.71 diluted EPS) vs $86.8M ($0.64) in Q1 and $92.5M ($0.68) in Q2 2023.
United Bankshares 8-K provides no clear material update; text unparseable.
Filing indicates Items 8.01 (Other Events) and 9.01 (Financials) but no press release content found.
United Bankshares shareholders elect 14 directors, ratify auditor, approve executive compensation
All 14 director nominees received majority votes; terms expire at 2025 Annual Meeting.
United Bankshares to acquire Piedmont Bancorp for ~$267M in stock
United will acquire all Piedmont shares at 0.300x UBSI shares; total consideration ~$267M.
United Bankshares Q1 2024 net income $86.8M ($0.64 EPS), down from $0.73 YoY
Net income $86.8M vs $98.3M in Q1 2023 and $79.4M in Q4 2023; diluted EPS $0.64.
appointed Dr. Sara DuMond to serve on the Board as an “independent” director to fill the vacancy created by that action. The appointment is effective October 21, 2024.
Max materiality 0.85 · Median 0.60 · Most common event earnings